Biogen announces $5 billion buyback days after shelving Alzheimer's trials
March 25, 2019 at 08:32 AM EDT
Biogen Inc said on Monday it would buy back shares worth $5 billion, days after its stock slumped on the drugmaker's announcement to end two Alzheimer's disease trials.
